Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Disorders of the Nervous System

Combined Treatment With Environmental Enrichment and (-)-Epigallocatechin-3-Gallate Ameliorates Learning Deficits and Hippocampal Alterations in a Mouse Model of Down Syndrome

Silvina Catuara-Solarz, Jose Espinosa-Carrasco, Ionas Erb, Klaus Langohr, Juan Ramon Gonzalez, Cedric Notredame and Mara Dierssen
eNeuro 19 October 2016, 3 (5) ENEURO.0103-16.2016; https://doi.org/10.1523/ENEURO.0103-16.2016
Silvina Catuara-Solarz
1Cellular and Systems Neurobiology, Systems Biology Program, the Barcelona Institute of Science and Technology, Centre for Genomic Regulation (CRG), 08003, Barcelona, Spain
2Universitat Pompeu Fabra (UPF), Barcelona, 08003, Spain
3Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, 08003, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Silvina Catuara-Solarz
Jose Espinosa-Carrasco
1Cellular and Systems Neurobiology, Systems Biology Program, the Barcelona Institute of Science and Technology, Centre for Genomic Regulation (CRG), 08003, Barcelona, Spain
2Universitat Pompeu Fabra (UPF), Barcelona, 08003, Spain
4Comparative Bioinformatics, Bioinformatics, and Genomics Program, Barcelona Institute of Science and Technology, Centre for Genomic Regulation, Barcelona, 08003, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jose Espinosa-Carrasco
Ionas Erb
2Universitat Pompeu Fabra (UPF), Barcelona, 08003, Spain
4Comparative Bioinformatics, Bioinformatics, and Genomics Program, Barcelona Institute of Science and Technology, Centre for Genomic Regulation, Barcelona, 08003, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ionas Erb
Klaus Langohr
3Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, 08003, Spain
5Department of Statistics and Operations Research, Universitat Politècnica De Catalunya/BarcelonaTech, Barcelona, 08034, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Klaus Langohr
Juan Ramon Gonzalez
6Centre for Research in Environmental Epidemiology, Barcelona, 08003, Spain
7Centro De Investigación Biomédica En Red De Epidemiología Y Salud Pública, Madrid, 28029, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cedric Notredame
2Universitat Pompeu Fabra (UPF), Barcelona, 08003, Spain
4Comparative Bioinformatics, Bioinformatics, and Genomics Program, Barcelona Institute of Science and Technology, Centre for Genomic Regulation, Barcelona, 08003, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mara Dierssen
1Cellular and Systems Neurobiology, Systems Biology Program, the Barcelona Institute of Science and Technology, Centre for Genomic Regulation (CRG), 08003, Barcelona, Spain
3Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, 08003, Spain
8Centro De Investigación Biomédica En Red De Enfermedades Raras, Madrid, 28029, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mara Dierssen
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/ENEURO.0103-16.2016
PubMed 
27844057
Published By 
Society for Neuroscience
History 
  • Received May 2, 2016
  • Revision received August 26, 2016
  • Accepted September 8, 2016
  • Published online October 19, 2016.
Copyright & Usage 
Copyright © 2016 Catuara-Solarz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Author Information

  1. Silvina Catuara-Solarz1,2,3,
  2. Jose Espinosa-Carrasco1,2,4,
  3. Ionas Erb2,4,
  4. Klaus Langohr3,5,
  5. Juan Ramon Gonzalez6,7,
  6. Cedric Notredame2,4 and
  7. Mara Dierssen1,3,8
  1. 1Cellular and Systems Neurobiology, Systems Biology Program, the Barcelona Institute of Science and Technology, Centre for Genomic Regulation (CRG), 08003, Barcelona, Spain
  2. 2Universitat Pompeu Fabra (UPF), Barcelona, 08003, Spain
  3. 3Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, 08003, Spain
  4. 4Comparative Bioinformatics, Bioinformatics, and Genomics Program, Barcelona Institute of Science and Technology, Centre for Genomic Regulation, Barcelona, 08003, Spain
  5. 5Department of Statistics and Operations Research, Universitat Politècnica De Catalunya/BarcelonaTech, Barcelona, 08034, Spain
  6. 6Centre for Research in Environmental Epidemiology, Barcelona, 08003, Spain
  7. 7Centro De Investigación Biomédica En Red De Epidemiología Y Salud Pública, Madrid, 28029, Spain
  8. 8Centro De Investigación Biomédica En Red De Enfermedades Raras, Madrid, 28029, Spain
  1. Correspondence should be addressed to M. Dierssen, Cellular and Systems Neurobiology, Systems Biology Program, Centre for Genomic Regulation, Dr. Aiguader 88, 08003 Barcelona, Spain. E-mail: mara.dierssen{at}crg.eu.
View Full Text

Author contributions

Disclosures

  • Authors report no conflict of interest.

  • Authors Contribution: S.C.S. designed research, performed research, analyzed data, wrote the paper; J.E.-C., I.E., K.L., J.R.G. analyzed data; C.N. supervised the PCA analysis; M.D. provided financial support, designed research, wrote the paper.

  • This research was supported by DIUE of Generalitat de Catalunya (Grups consolidats SGR 2014/1125); Fondation Jérôme Lejeune (Paris, France); Spanish Ministry of Economy and Finance (MINECO) grants SAF2013-49129-C2-1-R, BFU2011-28575, and MTM2015-64465-C2-1-R CDTI (“Smartfoods”); the CIBER of Rare Diseases (ISCIII initiative); and EU-Era Net Neuron PCIN-2013-060. The CRG has received support as a Severo Ochoa Center of Excellence SEV- 2012-O208. S.C.-S. received a FPI doctoral Fellowship from the MINECO (SAF2010-16427).

Funding

  • MINECO | Consejo Superior de Investigaciones Científicas (CSIC)

    501100003339; SAF2013-49129-C2-1-R
  • DIUE of Generalitat de Catalunya (Grups consolidats)

    SGR 2014/1125
  • Fondation Jérôme Lejeune

    N.A
  • CDTI Smartfoods, CIBER of Rare Disease ISCIII initiave

    N.A.
  • EU-Era Net Neuron

    PCIN-2013- 060
  • Severo Ochoa Center of Excellence

    SEV- 2012-0208

Other Version

  • You are viewing the most recent version of this article.
  • previous version (October 19, 2016).

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2025-07-16
to
E.g., 2025-07-16

Article usage: November 2016 to July 2025

AbstractFullPdf
Nov 201605927
Dec 201604224
Total 2016010151
Jan 201703012
Feb 201705015
Mar 201703813
Apr 2017101415
May 201792230
Jun 201761714
Jul 201711617
Aug 2017172924
Sep 2017254025
Oct 2017214433
Nov 2017255131
Dec 201721218
Total 2017135372237
Jan 201813419
Feb 2018102512
Mar 20187338
Apr 2018207245
May 2018106812
Jun 2018187236
Jul 201815449
Aug 2018227119
Sep 2018161036
Oct 2018181779
Nov 2018212243
Dec 2018122215
Total 20181821151173
Jan 201962414
Feb 201962357
Mar 2019101478
Apr 20193419
May 201933016
Jun 201924715
Jul 20194368
Aug 201983611
Oct 20195279
Nov 20199246
Dec 20198246
Total 20196488899
Jan 20207257
Feb 202042419
Mar 20203376
May 202082216
Jun 2020113413
Jul 202074724
Aug 20204164
Sep 202034116
Oct 20204809
Nov 202054411
Dec 20207709
Total 202063440134
Jan 20214376
Feb 20213455
Mar 202136512
Apr 20211726
May 202111497
Jun 20211527
Jul 202147522
Aug 20213526
Sep 20212418
Oct 202116617
Nov 202123712
Dec 20212539
Total 202137644117
Jan 20222449
Feb 20227307
Mar 20220389
Apr 20221727
May 202214919
Jun 20224596
Jul 20222456
Aug 2022342915
Sep 2022153515
Oct 202255518
Nov 20229368
Dec 20226208
Total 202286512127
Jan 202304412
Feb 20232301
Mar 20232333
Apr 202314416
May 202302818
Jun 20230428
Jul 202354829
Aug 202374127
Sep 20230367
Oct 202328810
Nov 202372047
Dec 2023165713
Total 202342695151
Jan 2024205211
Feb 202444310
Mar 202455421
Apr 202442669
May 202465419
Jun 202436114
Jul 20243529
Aug 202485418
Sep 20241436
Oct 202415512
Nov 20243636
Dec 202424811
Total 202460845146
Jan 202526318
Feb 2025127619
Mar 202587225
Apr 202504514
May 20252536
Jun 202596714
Jul 202532010
Total 202536396106
Total70560441341
Back to top

In this issue

eneuro: 3 (5)
eNeuro
Vol. 3, Issue 5
September/October 2016
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Combined Treatment With Environmental Enrichment and (-)-Epigallocatechin-3-Gallate Ameliorates Learning Deficits and Hippocampal Alterations in a Mouse Model of Down Syndrome
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Combined Treatment With Environmental Enrichment and (-)-Epigallocatechin-3-Gallate Ameliorates Learning Deficits and Hippocampal Alterations in a Mouse Model of Down Syndrome
Silvina Catuara-Solarz, Jose Espinosa-Carrasco, Ionas Erb, Klaus Langohr, Juan Ramon Gonzalez, Cedric Notredame, Mara Dierssen
eNeuro 19 October 2016, 3 (5) ENEURO.0103-16.2016; DOI: 10.1523/ENEURO.0103-16.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Combined Treatment With Environmental Enrichment and (-)-Epigallocatechin-3-Gallate Ameliorates Learning Deficits and Hippocampal Alterations in a Mouse Model of Down Syndrome
Silvina Catuara-Solarz, Jose Espinosa-Carrasco, Ionas Erb, Klaus Langohr, Juan Ramon Gonzalez, Cedric Notredame, Mara Dierssen
eNeuro 19 October 2016, 3 (5) ENEURO.0103-16.2016; DOI: 10.1523/ENEURO.0103-16.2016
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Statistical analysis
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • (-)-epigallocatechin-3-gallate
  • Down syndrome
  • environmental enrichment
  • Excitation-Inhibition Imbalance
  • neuroplasticity

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • Optogenetic Activation of β-Endorphin Terminals in the Medial Preoptic Nucleus Regulates Female Sexual Receptivity
  • Hsc70 Ameliorates the Vesicle Recycling Defects Caused by Excess α-Synuclein at Synapses
Show more New Research

Disorders of the Nervous System

  • Release of Extracellular Matrix Components after Human Traumatic Brain Injury
  • Gene variants related to primary familial brain calcification: perspectives from bibliometrics and meta-analysis
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.